BioHealth News Archive

Novavax Announces Facility Expansion to Support Global Vaccine Development | Novavax Inc. – IR Site

Novavax Announces Facility Expansion to Support Global Vaccine Development | Novavax Inc. – IR Site

GAITHERSBURG, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced…

Read More
What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal

What Floreo’s expansion into ADHD means for the autism-focused virtual reality startup – Washington Business Journal

Through a partnership with NIH, D.C. virtual reality startup Floreo is expanding from autism spectrum disorder to attention deficit hyperactivity disorder. Image: Floreo's platform…

Read More
Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch

Jaan Biotherapeutics Awarded NIH Grant to Advance Cardiac Muscle Regeneration Therapy – MarketWatch

Sep 05, 2020 (IssueWire via COMTEX) -- San Diego, Sep 5, 2020 (Issuewire.com) - Jaan Biotherapeutics ("JBT"), announced that it has been awarded a…

Read More
Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN)

Rexahn Pharmaceuticals Announces Stockholder Approval of All Proposals Required for Merger with Ocuphire Pharma :: Rexahn Pharmaceuticals, Inc. (REXN)

ROCKVILLE, Md., Nov. 02, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NASDAQ:REXN) (“Rexahn”) announced today that at its special meeting of stockholders held on…

Read More
Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire

Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease | Business Wire

GAITHERSBURG, Md.--(BUSINESS WIRE)--Neuraly, Inc., a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced it has received clearance of an investigational…

Read More
Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace

Emmes Employees Co-Author COVID-19 Vaccine Report for the New England Journal of Medicine | BioSpace

Three Emmes employees were among the co-authors of the recent report, "Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults."  The employees are…

Read More
JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz

JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences · BioBuzz

MADISON, Wis. and CAMBRIDGE, Mass., Oct. 27, 2020 /PRNewswire/ — Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. (“Thrive”), a healthcare company dedicated to incorporating earlier…

Read More
REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.

REGENXBIO to Receive $80.0 Million Milestone Payment from Novartis AG | REGENXBIO Inc.

ROCKVILLE, Md., Oct. 27, 2020 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential…

Read More
Strengths of Our Region: Combating Infectious Diseases Forum Roundup · BioBuzz

Strengths of Our Region: Combating Infectious Diseases Forum Roundup · BioBuzz

Over the past nine months, more than $7 billion in federal money has poured into the BioHealth Capital Region in support of therapies, diagnostics,…

Read More
New Johns Hopkins Center Will Research COVID-19 Immunity – CBS Baltimore

New Johns Hopkins Center Will Research COVID-19 Immunity – CBS Baltimore

ANNAPOLIS (WJZ) — A NIH initiative will fund a new Johns Hopkins center to research COVID-19 immunity as the pandemic continues to affect people…

Read More
Your Health in the “New Normal” of the Pandemic – An Industry Revolutionizing Healthcare As We Know It | Economic Alliance of Greater Baltimore

Your Health in the “New Normal” of the Pandemic – An Industry Revolutionizing Healthcare As We Know It | Economic Alliance of Greater Baltimore

Greater Baltimore is one of few regions ideally suited to pioneer the future of digital health, an industry that will revolutionize healthcare as we…

Read More
Emmes Selected as Corporate Achievement Award Winner by the Montgomery County Chamber of Commerce

Emmes Selected as Corporate Achievement Award Winner by the Montgomery County Chamber of Commerce

ROCKVILLE, Md., Oct. 29, 2020 /PRNewswire/ -- Emmes today announced that the Montgomery County Chamber of Commerce has selected Emmes as the recipient of its…

Read More
Angel Funders Report 2020

Angel Funders Report 2020

Leverage the only verified source of angel investment data to anticipate future trends with the Angel Funders Report 2020! The Angel Funders Report 2020…

Read More
U.S. Army Awards $599M in Contracts for AstraZeneca Vaccine, Lilly Antibody vs. COVID-19

U.S. Army Awards $599M in Contracts for AstraZeneca Vaccine, Lilly Antibody vs. COVID-19

The U.S. Army will spend a combined $599 million to procure two leading COVID-19 candidates—AstraZeneca’s vaccine AZD1222, co-developed with the University of Oxford and…

Read More

Fina Biosolutions has been issued European patent No. 3099800

Fina Biosolutions has been issued European patent No. 3099800, Expression and Purification of CRM Proteins and Related Proteins, and Protein Domains. The patent covers…

Read More